EMA Questions and Answers Regulation 2021_1248 Check at reception of Veterinary medicinal product Anastasija Eschricht2023-06-09T11:32:11+00:00December 7th, 2022|
FDA GFI, Completeness Assessments for Type II API DMFs Under GDUFA, 10/17 Beatrice Burtsov2022-12-06T12:53:31+00:00December 6th, 2022|
EMA Recommendation on Assessment of quality of medicinal products containing existing/known active substances, 02/09 Beatrice Burtsov2022-11-08T14:25:16+00:00November 8th, 2022|
EU Commission Implementing Regulation 2021/1280 GDP for API used as starting materials in veterinary medicinal products, 08/21 Beatrice Burtsov2022-02-22T15:46:56+00:00February 22nd, 2022|
PIC/S Good Practice Guidelines for Blood Establishments and Hospital Blood Banks, 06/21 Anna Sandberg2023-06-29T09:15:52+00:00September 28th, 2021|
EMA Q&A GMP requirements applicable to early manufacturing steps for comminuted plants and herbal extracts used as active substances, 02/21 Anna Sandberg2021-09-28T14:23:01+00:00September 28th, 2021|